Management of Post Menopausal Syndrome with unani medicine.
Phase 2
- Conditions
- Health Condition 1: R688- Other general symptoms and signsHealth Condition 2: R688- Other general symptoms and signsHealth Condition 3: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Registration Number
- CTRI/2023/06/054296
- Lead Sponsor
- Dr Khan Bashayer Sarwar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Women experiencing symptoms accompanying natural menopause ( during perimenopause or postmenopausal periods) or surgical menopause.
Women with diabetes and hypertension have been included.
Clinically stable patient.
Exclusion Criteria
Women with any kind of malignancies.
Women with undiagnosed vaginal bleeding.
Patient with deranged kidney, hepatic and
Cardiac profiles.
Daignosed patients of psychiatric disorders.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Any effect like cure, improved, relieved or worsenTimepoint: 3 months
- Secondary Outcome Measures
Name Time Method Any effect on quality of lifeTimepoint: 18 months